Logo

Paracel Sells GeneMatcher Analysis Engine to Incyte

Dec 31, 1999
Premium

P

ASADENA, Calif.--Paracel announced last month that Incyte Pharmaceuticals has purchased Paracel’s massively parallel genetic data analysis engine for high-throughput search and annotation, GeneMatcher. Steve Lincoln, Incyte’s vice-president for bioinformatics R&D, said GeneMatcher is particularly well-suited for the high-thoughput application of hidden Markov models. "The scientific accuracy of GeneMatcher is an important element in Incyte’s ability to develop valuable databases for medical researchers," he added.

Filed under

Informatics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.